open access

Vol 12, No 2 (2011): Practical Diabetology
Review articles (submitted)
Published online: 2011-08-05
Get Citation

Biphasic insulin analogues vs. premixed human insulin — clinically significant differences. Diabetologist’s and cardiologist’s point of view

Teresa Koblik, Grzegorz Gajos
Diabetologia Praktyczna 2011;12(2):31-41.

open access

Vol 12, No 2 (2011): Practical Diabetology
Review articles (submitted)
Published online: 2011-08-05

Abstract

The article presents two different points of view regarding clinical use of biphasic insulin analogues and premixed human insulin: diabetologist and cardiologist.
The common focus areas for both specialities are postprandial hyperglycaemia as a key factor responsible for macrovascular complications and hypoglycaemia and its potential influence on cardiovascular system.
The prandial insulin response is an independent risk factor for cardiovascular disease. Recent clinical studies have strengthened the evidence for a causal relationship between postprandial hyperglycaemic peaks and macrovascular disease. PPG is targeted as an important parameter in treatment strategy. In several studies use of biphasic insulin analogues resulted in better postprandial plasma glucose control than similar regimens of premixed human insulin. Severe hypoglycaemia can lead to serious CV events. Episodes of mild and severe hypoglycaemia deteriorate the prognosis in diabetic patients with cardiovascular disorders to the same extent as hyperglycaemia.
Biphasic insulin analogues therapy achieved better safety profile with the reduced number of major and nocturnal hypoglycaemic episodes compared to premixed human insulin.
The optimal treatment of type 2 diabetic patients, especially these with cardiovascular diseases, should concentrate on avoiding postprandial hyperglycaemia and concomitant rapid glycaemic excursions, especially hypoglycaemia. In both aspects biphasic insulin analogues show clinically significant advantages compared with premixed human insulin.
(Diabet. Prakt. 2011; 12, 2: 31–41)

Abstract

The article presents two different points of view regarding clinical use of biphasic insulin analogues and premixed human insulin: diabetologist and cardiologist.
The common focus areas for both specialities are postprandial hyperglycaemia as a key factor responsible for macrovascular complications and hypoglycaemia and its potential influence on cardiovascular system.
The prandial insulin response is an independent risk factor for cardiovascular disease. Recent clinical studies have strengthened the evidence for a causal relationship between postprandial hyperglycaemic peaks and macrovascular disease. PPG is targeted as an important parameter in treatment strategy. In several studies use of biphasic insulin analogues resulted in better postprandial plasma glucose control than similar regimens of premixed human insulin. Severe hypoglycaemia can lead to serious CV events. Episodes of mild and severe hypoglycaemia deteriorate the prognosis in diabetic patients with cardiovascular disorders to the same extent as hyperglycaemia.
Biphasic insulin analogues therapy achieved better safety profile with the reduced number of major and nocturnal hypoglycaemic episodes compared to premixed human insulin.
The optimal treatment of type 2 diabetic patients, especially these with cardiovascular diseases, should concentrate on avoiding postprandial hyperglycaemia and concomitant rapid glycaemic excursions, especially hypoglycaemia. In both aspects biphasic insulin analogues show clinically significant advantages compared with premixed human insulin.
(Diabet. Prakt. 2011; 12, 2: 31–41)
Get Citation

Keywords

postprandial hyperglycaemia; glycaemic excursions; hypoglycaemia; biphasic insulin analogues; premixed human insulin

About this article
Title

Biphasic insulin analogues vs. premixed human insulin — clinically significant differences. Diabetologist’s and cardiologist’s point of view

Journal

Clinical Diabetology

Issue

Vol 12, No 2 (2011): Practical Diabetology

Pages

31-41

Published online

2011-08-05

Bibliographic record

Diabetologia Praktyczna 2011;12(2):31-41.

Keywords

postprandial hyperglycaemia
glycaemic excursions
hypoglycaemia
biphasic insulin analogues
premixed human insulin

Authors

Teresa Koblik
Grzegorz Gajos

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl